Sars cov 2 d614g wt s

Manufactured by Sino Biological

The SARS-CoV-2 D614G WT S is a recombinant protein that represents the wild-type spike (S) protein of the SARS-CoV-2 virus with the D614G mutation. It is a tool for research and development purposes.

Automatically generated - may contain errors

Lab products found in correlation

Sars cov 2 s1, by Sino Biological (3 mentions) Sars cov 2 s2, by Sino Biological (3 mentions) Kappa b 1.617.1 s, by Sino Biological (2 mentions) Delta b 1.617.2 s, by Sino Biological (2 mentions) Delta b 1, by Sino Biological (1 mentions) Hcov oc43 s, by Sino Biological (1 mentions) Sars cov 2 rbd, by Sino Biological (1 mentions) Sars cov 2 ntd, by Sino Biological (1 mentions)

Spelling variants of this product

SARS-CoV-2 S (4 citations) SARS-CoV-2 WT-S, (2 citations)

3 protocols using sars cov 2 d614g wt s

Multiplex SARS-CoV-2 Antibody Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols

Antigens used for Luminex based assays: SARS-CoV-2 D614G WT S (kindly provided by Erica Saphire, La Jolla Institute for Immunology), SARS-CoV-2 S1 (Sino Biological), SARS-CoV-2 S2 (Sino Biological) and SARS-CoV-2 RBD (kindly provided by Aaron Schmidt, Ragon Institute) as well as SARS-CoV-2 VOC,s such as Alpha B.1.1.7 S (LakePharma), Beta B.1.351 S (LakePharma), Gamma P1 S (LakePharma), Epsilon B.1.427 (kindly provided by Erica Saphire, La Jolla Institute for Immunology), Iota B.1.526 (LakePharma), Kappa B.1.617.1 S (Sino Biological) and Delta B.1.617.2 S (kindly provided by Erica Saphire, La Jolla Institute for Immunology) and Alpha B.1.1.7, Beta B.1.351, Gamma P1, Kappa B.1.617.2 and Delta B.1.617.2 RBDs (kindly provided by Florian Krammer, Icahn School of Medicine at Mount Sinai).

Kaplonek P., Cizmeci D., Fischinger S., Collier A.R., Suscovich T., Linde C., Broge T., Mann C., Amanat F., Dayal D., Rhee J., de St. Aubin M., Nilles E.J., Musk E.R., Menon A.S., Saphire E.O., Krammer F., Lauffenburger D.A., Barouch D.H, & Alter G. (2021). Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profiles. bioRxiv.

+ Open protocol

+ Expand

Luminex-based SARS-CoV-2 Variant Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols

Antigens used for Luminex-based assays are: SARS-CoV-2 D614G WT S (kindly provided by E. Saphire, La Jolla Institute for Immunology), SARS-CoV-2 S1 (Sino Biological), SARS-CoV-2 S2 (Sino Biological) and SARS-CoV-2 RBD (kindly provided by A. Schmidt, Ragon Institute) as well as SARS-CoV-2 VOCs, such as alpha B.1.1.7 S (LakePharma), beta B.1.351S (LakePharma), gamma P1 S (LakePharma), kappa B.1.617.1 S (Sino Biological) and delta B.1.617.2S (kindly provided by E. Saphire) and alpha B.1.1.7, beta B.1.351, gamma P1, kappa B.1.617.2 and delta B.1.617.2 RBDs (kindly provided by F. Krammer, Icahn School of Medicine at Mount Sinai) and hCoV-OC43 S (Sino Biological) and hCoV-HKU1 S (Immune Tech).

Kaplonek P., Cizmeci D., Kwatra G., Izu A., Lee J.S., Bertera H.L., Fischinger S., Mann C., Amanat F., Wang W., Koen A.L., Fairlie L., Cutland C.L., Ahmed K., Dheda K., Barnabas S.L., Bhorat Q.E., Briner C., Krammer F., Saphire E.O., Gilbert S.C., Lambe T., Pollard A.J., Nunes M., Wuhrer M., Lauffenburger D.A., Madhi S.A, & Alter G. (2023). ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19. Nature Immunology, 24(7), 1161-1172.

+ Open protocol

+ Expand

SARS-CoV-2 Antigen Luminex Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols

The antigens used for Luminex-based assays are as follows: SARS-CoV-2 D614G WT S (provided by Erica Saphire, La Jolla Institute for Immunology), SARS-CoV-2 S1 (Sino Biological), SARS-CoV-2 S2 (Sino Biological) and SARS-CoV-2 RBD (kindly provided by Aaron Schmidt, Ragon Institute), and SARS-CoV-2 NTD (Sino Biological).

Bowman K.A., Stein D., Shin S., Ferbas K.G., Tobin N.H., Mann C., Fischinger S., Ollmann Saphire E., Lauffenburger D., Rimoin A.W., Aldrovandi G, & Alter G. (2022). Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity. mBio, 13(5), e01647-22.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!